Breast Cancer Coverage from Every Angle
Advertisement
Advertisement

Recent News

ASTRO 2022: Long-Term Outcomes With a Three-Fraction Partial-Breast Irradiation Strategy
EBCC 2022: Are Changes in Blood Proteins an Early Signal of Breast Cancer?
SITC 2022: Neoantigen-Specific Antibody Responses in Metastatic Triple-Negative Breast Cancer
EBCC 2022: Risk Prediction Model and Individualizing Breast Cancer Screening Strategies
SITC 2022: Neoadjuvant Combination of Radiotherapy and Pembrolizumab in Triple-Negative Breast Cancer
ASTRO 2022: Can Regional Node Irradiation Reduce Risk for Locoregional Breast Cancer Recurrence?
ASTRO 2022: Phase III Trial Compares 3 Versus 6 Weeks of Radiation Therapy for Early-Stage Breast Cancer
Dose-Dense Adjuvant Chemotherapy in Early-Stage Breast Cancer: 15-Year Italian Trial Update
Identifying Genomic Characteristics of Breast Cancers Linked to PTEN Hamartoma Tumor Syndrome
ASTRO 2022: Radiation Dose and Long-Term Lymphedema Risk in Patients With Breast Cancer
ASTRO 2022: Final Study Results With Accelerated Partial Breast Irradiation for Early-Stage Breast Cancer
Can a Silicone-Based Polyurethane Film Dressing Prevent Acute Radiation Dermatitis in Breast Cancer?
Darolutamide for AR-Positive, Advanced Triple-Negative Breast Cancer: Phase II Study Results
Adding Palbociclib to Standard Adjuvant Endocrine Therapy for Estrogen Receptor–Positive Breast Cancer
Adjuvant Goserelin and Tamoxifen in Premenopausal Patients With Breast Cancer: 20-Year Trial Update
Can Hand Cooling and Compression Prevent Nerve Pain in Patients With Breast Cancer?
Neoadjuvant Endocrine Therapy for Breast Cancer: Differential Responses in Black Versus White Women
Phase III DAWNA-2 Trial: Dalpiciclib Plus Endocrine Therapy for Advanced Breast Cancer
FDA Brief: Priority Review for Sacituzumab Govitecan in HR-Positive, HER2-Negative Metastatic Breast Cancer
ASCO Quality 2022: Causes of Variation in Receipt of Axillary Surgery in Older Patients With Breast Cancer
Blocking CD73 With Oleclumab in Combination Therapy for Triple-Negative Breast Cancer
ASCO Quality 2022: Survey Identifies Knowledge Gaps in Breast Cancer Screening Practices for Transgender People
Patterns of Genomic Instability and Resistance to Endocrine Therapy in Metastatic Breast Cancer
ESMO 2022: Biomarker Analyses Focus on Resistance to T-DXd in Metastatic Breast Cancer
Oral Versus Intravenous Paclitaxel Treatment in Metastatic Breast Cancer
ESMO 2022: Overall Survival Data From MonarcHER Support Abemaciclib-Based Therapy for Advanced Breast Cancer
ESMO 2022: Patient-Reported Outcomes From DESTINY-Breast04 in Metastatic Breast Cancer
ESMO 2022: MONARCH 3 Survival Update on Abemaciclib-Based Therapy for Advanced Breast Cancer
ESMO 2022: Overall Survival Update From TROPiCS-02 Trial of Sacituzumab Govitecan in Metastatic Breast Cancer
FDA Safety Alert: Skin Cancer and Various Lymphomas in Scar Tissue Around Breast Implants
ESMO 2022: METEORA-II Trial Evaluates Triplet Regimen in Advanced Breast Cancer
ESMO 2022: Chemotherapy Plus Immunotherapy for Estrogen Receptor–Positive Metastatic Breast Cancer
Metastatic Breast Cancer: Does Collagen Play a Role in the Microenvironment?
Does Neurotoxic Chemotherapy Induce Hearing Problems in Cancer Survivors?
Using Nanomedicine to Target Tumors and Lymph Nodes in Triple-Negative Breast Cancer
Are Breast Cancer Survivors Adequately Informed About Sexual Health Effects? Study Says Maybe Not
MRI After Silicone Implant Breast Surgery: How Many Women Are Really Being Screened?
Development of an Asian Population–Specific BRCA Mutation Prediction Model
Supine Versus Prone Breast Radiotherapy: Impact on the Skin of Women With Large Breasts
FDA Grants Priority Review to Elacestrant in Advanced Breast Cancer
Can Ceritinib Combination Therapy Reduce the Growth of Triple-Negative Breast Cancer?
T-DXd: First Targeted Therapy for HER2-Low Breast Cancer Approved by the FDA
Plant-Based Diets and Risk of Developing Breast Cancer in Older Women
New Metric May Help to Predict Long-Term Survival in Triple-Negative Breast Cancer
T-DXd Granted Priority Review by the FDA in HER2-Low Metastatic Breast Cancer
Is the Risk of Breast Cancer in Men Influenced by Infertility?
Updated ASCO Guideline for the Use of Biomarkers in Early-Stage Breast Cancer
Ancestry-Specific Risks of Triple-Negative Breast Cancer and Genetic Mutations
FDA Brief: Biologics License Application Accepted for Trastuzumab Duocarmazine in Advanced Breast Cancer
Does a Live Birth After Treatment for Breast Cancer Affect a Woman’s Survival?
FAKTION Trial: Mature Survival Data on Use of Fulvestrant Plus Capivasertib in Metastatic Breast Cancer
Impact of Diet and Exercise on Chemotherapy Completion in Patients With Breast Cancer
Reanalysis of BIG 1-98, SOFT, and TEXT Trials: Focus on Clinical High-Risk Subgroups
Novel Genomic Test May Predict Response to Dose-Dense Chemotherapy in Breast Cancer
ASCO 2022: Adjuvant Endocrine Therapy Plus Chemotherapy in Older Women With Breast Cancer
ASCO 2022: Long-Term Benefits of Denosumab Reported in Hormone Receptor–Positive Breast Cancer
Study Identifies Genetic Locus Potentially Linked to Treatment Response in Breast Cancer
ASCO 2022: Updated Safety Data From DESTINY-Breast03 on T-DXd Versus T-DM1 in Metastatic Breast Cancer
Do Diabetes and Glycemic Control Impact Outcomes in Patients With Metastatic Breast Cancer?
ASCO 2022: Endocrine Therapy Plus Ribociclib for CDK4/6 Inhibitor–Resistant Metastatic Breast Cancer
ASCO 2022: Novel HER3-Directed Antibody-Drug Conjugate Under Study in Metastatic Breast Cancer
ASCO 2022: Survival Update From PALOMA-2 With Palbociclib Plus Letrozole in Advanced Breast Cancer
ASCO 2022: Can Some Older Women With Breast Cancer Avoid Radiotherapy After Breast-Conserving Surgery?
ASCO 2022: DESTINY-Breast04 Reports Benefit of T-DXd in HER2-Low Metastatic Breast Cancer
ASCO 2022: TROPiCS-02 Meets Study Endpoint With Sacituzumab Govitecan-hziy in Advanced Breast Cancer
CDK Inhibition Plus Endocrine Therapy for Breast Cancer: Case Presentations
Novel Imaging Agent Under Study in Breast-Conserving Surgery: Focus on Intraoperative Margins


By continuing to browse this site you permit us and our partners to place identification cookies on your browser and agree to our use of cookies to identify you for marketing. Read our Privacy Policy to learn more.